Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 SomaLogic Expands Agreement with Novo Nordisk to 2025 | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

SomaLogic Expands Agreement with Novo Nordisk to 2025

Novo Nordisk will extend its use of SomaLogic’s proteomics technologies in drug research and development.

By: Anthony Vecchione

SomaLogic, Inc., a company involved in proteomics technology, is extending its collaborative agreement with Novo Nordisk. As part of the agreement, which now extends into the end of 2025, Novo Nordisk will expand its use of the SomaScan proteomics platform in drug research and development. Novo Nordisk will also use SomaLogic’s SomaSignal tests for investigations into cardiometabolic and other diseases. The extension builds upon an agreement between the two companies, which was announced in 2021.

Novo Nordisk previously partnered with SomaLogic to provide proteins of interest that expanded the SomaScan platform’s previous offering to its current offering of more than 7,000 proteins. SomaLogic’s proprietary protein detection and analysis technology measures how proteins function and interact, supporting researchers in drug research and development, and biomarker identification efforts.

“SomaLogic has been very pleased with our partnership with Novo Nordisk which spans more than a decade,” said SomaLogic CEO Adam Taich. “We are proud that our SomaScan platform is being used in their research and development of new potential treatments for serious chronic diseases.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics